SMFM Consult Series 61: Anticoagulation in pregnant patients with cardiac disease

Article

View the latest recommendations from the Society for Maternal-Fetal Medicine on anticoagulation in pregnant patients with cardiac disease.

Download PDF

Lifelong therapeutic anticoagulation is a principal component of the medical management of mechanical heart valves to prevent valve thrombosis.

Anticoagulation regimens indicated outside of pregnancy for patients with mechanical valves should be continued during pregnancy with the possibility of modifications based on the type of valve, the trimester of pregnancy, individual risk tolerance, and circumstances around the time of delivery. The purpose of this document is to provide recommendations regarding the management of anticoagulation for common cardiac conditions complicating pregnancy, including mechanical heart valves, atrial fibrillation, systolic heart failure, and congenital heart disease.

Recent Videos
March of Dimes 2024 Report highlights preterm birth crisis | Image Credit: marchofdimes.org
Understanding and managing postpartum hemorrhage: Insights from Kameelah Phillips, MD | Image Credit: callawomenshealth.com
Understanding cardiovascular risk factors in women | Image Credit: cedars-sinai.org.
Updated FLUBLOK label expands influenza vaccine options for pregnant women | Image Credit: mass-vaccination-resources.org
March of Dimes reports increase in maternity care desert prevalence | Image Credit: marchofdimes.org.
Discussing low-dose aspirin use for preeclampsia prevention | Image Credit: komodohealth.com
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit: cdc.gov
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit: uofmhealth.org.
Related Content
Contemporary OB/GYN week in review: Avian influenza, US health rankings, and more | Image Credit: © Aleksey 159 - © Aleksey 159 - stock.adobe.com.

Contemporary OB/GYN week in review: Avian influenza, US health rankings, and more

Celeste Krewson, Assistant Editor
December 20th 2024
Article

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Read More

S4E1: New RNA platform can predict pregnancy complications

S4E1: New RNA platform can predict pregnancy complications

February 11th 2022
Podcast

In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.

Listen

Anxiety and depression odds increased by spontaneous miscarriage | Image Credit: © tadamichi - © tadamichi - stock.adobe.com.

Anxiety and depression odds increased by spontaneous miscarriage

Celeste Krewson, Assistant Editor
December 18th 2024
Article

A new study highlights a significant association between spontaneous miscarriage and increased risks of anxiety and depression, especially among women with low social support.

Read More

Current state of COVID-19

Current state of COVID-19

Angie DeRosa;Lindsey Carr, Editor
August 20th 2021
Podcast

Contemporary OB/GYN Senior Editor Angie DeRosa gets insight on the current state of COVID-19 from Christina Han, MD, division director of maternal-fetal medicine at the University of California, Los Angeles, and member of its COVID-19 task force. Han is an active member of the Society for Maternal-Fetal Medicine and discusses the issues on behalf of SMFM.

Listen

Exploring preconception, prenatal, and postpartum care for patients in their 50s | Image Credit: © Natalya Lys - © Natalya Lys - stock.adobe.com.

Exploring preconception, prenatal, and postpartum care for patients in their 50s

Rachel A. Newman, MD, MBA;Tania F. Esakoff, MD
December 10th 2024
Article

Advances in reproductive technology are making pregnancies over the age of 50 years possible, but they come with unique challenges, requiring tailored prenatal and postpartum care.

Read More

Expert consensus sheds light on diagnosis and management of vasa previa | Image Credit: © MQ-Illustrations - © MQ-Illustrations - stock.adobe.com.

Expert consensus sheds light on diagnosis and management of vasa previa

Celeste Krewson, Assistant Editor
December 5th 2024
Article

A recent review established guidelines for prenatal diagnosis and care of vasa previa, outlining its definition, screening and diagnosis, management, and timing of delivery in asymptomatic patients.

Read More

© 2024 MJH Life Sciences

All rights reserved.